Biofil Chemicals & Pharmaceuticals Ltd

NSE :BIOFILCHEM BSE :524396 Sector : Pharmaceuticals

Buy, Sell or Hold BIOFILCHEM? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

15 Jan
148.05
(-4.97%)

14 Jan
155.80
(-5.00%)

13 Jan
164.00
(4.99%)

12 Jan
156.20
(-4.99%)

11 Jan
164.40
(-5.00%)

08 Jan
173.05
(-5.00%)

07 Jan
182.15
(-4.98%)

06 Jan
191.70
(-4.98%)

05 Jan
201.75
(5.00%)

04 Jan
192.15
(5.00%)

01 Jan
183.00
(4.99%)

31 Dec
174.30
(-4.99%)

30 Dec
183.45
(-5.00%)

29 Dec
193.10
(-4.99%)

28 Dec
203.25
(-4.98%)

24 Dec
213.90
(-5.00%)

23 Dec
225.15
(-4.98%)

22 Dec
236.95
(-4.99%)

21 Dec
249.40
(-4.99%)

18 Dec
262.50
(-4.99%)

17 Dec
276.30
(-4.99%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish

Medium Term Investors

Very Bearish

Long Term Investors

Bullish

Moving Averages

5 DMA

Bearish

156.21

10 DMA

Bearish

171.28

20 DMA

Bearish

190.86

50 DMA

Bearish

202.35

100 DMA

Bullish

132.09

200 DMA

Bullish

74.2

Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Jan 15, 2021 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	148.05	148.05	148.05	-	-
R2	148.05	148.05	148.05	148.05	-
R1	148.05	148.05	148.05	148.05	148.05
P	148.05	148.05	148.05	148.05	148.05
S1	148.05	148.05	148.05	148.05	148.05
S2	148.05	148.05	148.05	148.05	-
S3	148.05	148.05	148.05	-	-

Key Metrics

Shareholding Pattern

	46.82%	Total Promoter Holding

	0.45%	Mutual Fund Holdings

	0%	FIIs

	52.65%	Non Institution

	0%	Insurance Companies

	0%	Custodians

	0.08%	Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Consolidated
Standalone

Biofil Chemicals & Pharmaceuticals Ltd Quaterly Results


INCOME
PROFIT
EPS

Biofil Chemicals & Pharmaceuticals Ltd Quaterly Results


INCOME	11.66	12.84	3.75	2.94	16.16
PROFIT	0.79	0.23	0.15	0.22	0.93
EPS	0.49	0.14	0.11	0.13	0.57

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Biofil Chemicals & Pharmaceuticals Ltd Profit & Loss


INCOME
PROFIT
EPS

Biofil Chemicals & Pharmaceuticals Ltd Profit & Loss

	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
INCOME	4.42	6.31	6.32	7.05	6.3	13.69	13.6	13.38	23.06	30.2
PROFIT	0.99	0.15	0.54	0.52	0.59	0.78	1.79	0.47	0.48	1.21
EPS	0.61	0.09	0.33	0.32	0.36	0.48	1.1	0.29	0.3	0.74

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
SOURCES OF FUNDS :
Share Capital	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27	16.27
Reserves Total	-1.39	-2.62	-3.11	-3.58	-5.37	-7.86	-8.41	-8.91	-9.44	-9.57
Total Shareholders Funds	14.88	13.65	13.16	12.69	10.9	8.41	7.86	7.36	6.83	6.7
Unsecured Loans	1.19	1.64	1.56	1.43	1.37	2.98	2.87	2.79	2.49	1.3
Total Debt	1.19	1.64	1.56	1.43	1.37	2.98	2.87	2.79	2.49	1.3
Total Liabilities	16.07	15.29	14.72	14.12	12.27	11.39	10.73	10.15	9.32	8
APPLICATION OF FUNDS :
Gross Block	11.45	11.24	9.83	9.45	11.04	10.85	10.68	10.44	10.14	9.33
Less : Accumulated Depreciation	1.36	0.95	0.59	0.29	2.06	1.79	1.51	1.27	1.04	0.84
Net Block	10.09	10.29	9.24	9.16	8.98	9.06	9.17	9.17	9.1	8.49
Inventories	1.69	1.19	1.02	0.17	0.1	0.17	0.27	0.32	0.22	0.06
Sundry Debtors	29.71	12.03	12.98	11.46	13.98	3.65	4.1	3.34	4.11	1.5
Cash and Bank Balance	0.26	0.14	0.37	0.31	0.18	0.13	0.18	0.13	0.25	0.09
Loans and Advances	0.62	0.57	0.53	0.74	0.89	0.75	0.87	0.53	0.42	0.24
Total Current Assets	32.27	13.92	14.91	12.68	15.16	4.7	5.43	4.32	5.01	1.89
Current Liabilities	26.04	8.81	9.32	7.22	11.59	2.11	3.64	3.11	4.73	2.35
Provisions	0.25	0.12	0.11	0.5	0.26	0.25	0.23	0.23	0.06	0.03
Total Current Liabilities & Provisions	26.29	8.93	9.43	7.72	11.86	2.36	3.87	3.34	4.78	2.38
Net Current Assets	5.98	4.99	5.48	4.96	3.3	2.34	1.56	0.99	0.23	-0.49
Total Assets	16.07	15.28	14.73	14.12	12.28	11.4	10.73	10.16	9.33	8

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity 0.89

Net Profit before Tax and Extr...	1.46
Depreciation	0.41
Interest (Net)	0.12
Prov. and W/O (Net)	0.03
Total Adjustments (PBT and Ext...	0.56
Operating Profit before Workin...	2.02
Trade and 0ther Receivables	-17.83
Inventories	-0.5
Trade Payables	17.33
Total Adjustments (OP before W...	-1.02
Cash Generated from/(used in) ...	1
Direct Taxes Paid	-0.11
Total Adjustments(Cash Generat...	-0.11
Cash Flow before Extraordinary...	0.89
Net Cash from Operating Activi...	0.89

Cash from Investing Activity -0.21

Purchased of Fixed Assets	-0.21
Net Cash used in Investing Act...	-0.21

Cash from Financing Activity -0.57

Of the Long Tem Borrowings	-0.45
Interest Paid	-0.12
Net Cash used in Financing Act...	-0.57

News

Company Details

Registered Office
Address	11/12 Sector E Sanwer Road, Sanwer Road Industrial Area
City	Indore
State	Madhya Pradesh
Pin Code	452015
Tel. No.	91-731-2426700
Fax. No.	91-731-2420926
Email	bcplcompliance@gmail.com
Internet	http://www.biofilgroup.net

Registrars
Address	11/12 Sector E Sanwer Road
City	Indore
State	Madhya Pradesh
Pin Code	452015
Tel. No.	91-731-2426700
Fax. No.	91-731-2420926
Email	bcplcompliance@gmail.com
Internet	http://www.biofilgroup.net

Management
Name	Designation
Ramesh Shah	Managing Director
Romil Shah	Non Executive Director
Shaila Jain	Independent Director
Subhash Chandra Swarnkar	Independent Director

EquityPandit

Copyright © 2014 EquityPandit Financial Services Pvt. Ltd.
All rights reserved.

SEBI Registered Investment Advisor
SEBI Registration Number : INA000006688
An ISO 9001:2008 Certified Company
Investment/Trading in markets is subject to market risk.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.